Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Comparative Effects of Methylphenidate, Modafinil, and MDMA on Response Inhibition Neural Networks in Healthy Subjects
André Schmidt, Felix Müller, Patrick C. Dolder, et al.
The International Journal of Neuropsychopharmacology (2017) Vol. 20, Iss. 9, pp. 712-720
Open Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

Neurotransmitter function
Mitul A. Mehta, Peter C.T. Hawkins
Elsevier eBooks (2024), pp. 136-151
Closed Access | Times Cited: 42
MDMA and MDMA-Assisted Therapy
Aaron Wolfgang, Gregory A. Fonzo, Joshua C. Gray, et al.
American Journal of Psychiatry (2025) Vol. 182, Iss. 1, pp. 79-103
Closed Access | Times Cited: 4
Receptor-Enriched Analysis of functional connectivity by targets (REACT): A novel, multimodal analytical approach informed by PET to study the pharmacodynamic response of the brain under MDMA
Ottavia Dipasquale, Pierluigi Selvaggi, Mattia Veronese, et al.
NeuroImage (2019) Vol. 195, pp. 252-260
Open Access | Times Cited: 56
Acute LSD effects on response inhibition neural networks
André Schmidt, Felix Müller, Claudia Lenz, et al.
Psychological Medicine (2017) Vol. 48, Iss. 9, pp. 1464-1473
Open Access | Times Cited: 54
Cognitive enhancement effects of stimulants: a randomized controlled trial testing methylphenidate, modafinil, and caffeine
Dimitris Repantis, Leonore Bovy, Kathrin Ohla, et al.
Psychopharmacology (2020) Vol. 238, Iss. 2, pp. 441-451
Open Access | Times Cited: 47
How effective are pharmaceuticals for cognitive enhancement in healthy adults? A series of meta-analyses of cognitive performance during acute administration of modafinil, methylphenidate and D-amphetamine
Carl Roberts, Andrew Jones, Harry Sumnall, et al.
European Neuropsychopharmacology (2020) Vol. 38, pp. 40-62
Open Access | Times Cited: 43
The Ability to Voluntarily Regulate Theta Band Activity Affects How Pharmacological Manipulation of the Catecholaminergic System Impacts Cognitive Control
Astrid Prochnow, Moritz Mückschel, Elena Eggert, et al.
The International Journal of Neuropsychopharmacology (2024) Vol. 27, Iss. 1
Open Access | Times Cited: 4
A Systematic Review of the Neurocognitive Effects of Psychedelics in Healthy Populations: Implications for Depressive Disorders and Post-Traumatic Stress Disorder
Mario Renato Velit-Salazar, Paulo Shiroma, Eloise Cherian
Brain Sciences (2024) Vol. 14, Iss. 3, pp. 248-248
Open Access | Times Cited: 4
Towards Combinatorial Approaches for Preserving Cognitive Fitness in Aging
Anna‐Katharine Brem, Stefano L. Sensi
Trends in Neurosciences (2018) Vol. 41, Iss. 12, pp. 885-897
Closed Access | Times Cited: 32
Cognitive enhancement: Effects of methylphenidate, modafinil, and caffeine on latent memory and resting state functional connectivity in healthy adults
Maxi Becker, Dimitris Repantis, Martin Dresler, et al.
Human Brain Mapping (2022) Vol. 43, Iss. 14, pp. 4225-4238
Open Access | Times Cited: 18
Cognitive functioning associated with acute and subacute effects of classic psychedelics and MDMA - a systematic review and meta-analysis
Lukas A. Basedow, Tomislav Majić, Nicklas Jakob Hafiz, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
Emotional and sensory dysregulation as a possible missing link in attention deficit hyperactivity disorder: A review
Anna Grossman, A. Avital
Frontiers in Behavioral Neuroscience (2023) Vol. 17
Open Access | Times Cited: 7
Fronto-parietal engagement in response inhibition is inversely scaled with attention-deficit/hyperactivity disorder symptom severity
Tamar Kolodny, Carmel Mevorach, Pnina Stern, et al.
NeuroImage Clinical (2019) Vol. 25, pp. 102119-102119
Open Access | Times Cited: 22
Functional imaging studies of acute administration of classic psychedelics, ketamine, and MDMA: Methodological limitations and convergent results
Sophia Linguiti, Jacob W. Vogel, Valerie J. Sydnor, et al.
Neuroscience & Biobehavioral Reviews (2023) Vol. 154, pp. 105421-105421
Closed Access | Times Cited: 6
Acute Effects of Methylphenidate, Modafinil, and MDMA on Negative Emotion Processing
André Schmidt, Felix Müller, Patrick C. Dolder, et al.
The International Journal of Neuropsychopharmacology (2017) Vol. 21, Iss. 4, pp. 345-354
Open Access | Times Cited: 19
Cortico-Amygdala-Striatal Activation by Modafinil/Flecainide Combination
Dominique Vodovar, Adeline Duchêne, Catriona Wimberley, et al.
The International Journal of Neuropsychopharmacology (2018) Vol. 21, Iss. 7, pp. 687-696
Open Access | Times Cited: 17
A State-of-the-Art Review on the Use of Modafinil as A Performance-enhancing Drug in the Context of Military Operationality
Martine Van Puyvelde, Jeroen Van Cutsem, Émilie Lacroix, et al.
Military Medicine (2021) Vol. 187, Iss. 11-12, pp. 1286-1298
Open Access | Times Cited: 14
A Systematic Review of Neurocognitive Effects of Subanesthetic Doses of Intravenous Ketamine in Major Depressive Disorder, Post-Traumatic Stress Disorder, and Healthy Population
Paulo Shiroma, Mario Renato Velit-Salazar, Yelena Vorobyov
Clinical Drug Investigation (2022) Vol. 42, Iss. 7, pp. 549-566
Closed Access | Times Cited: 9
Article Commentary: Pharmacokinetic and Pharmacodynamic of the Cognitive Enhancer Modafinil: Relevant Clinical and Forensic Aspects
Ana Catarina Sousa, Ricardo Jorge Dinis‐Oliveira
Substance Abuse (2020) Vol. 41, Iss. 2, pp. 155-173
Closed Access | Times Cited: 14
Modafinil enhances cognitive, but not emotional conflict processing via enhanced inferior frontal gyrus activation and its communication with the dorsomedial prefrontal cortex
Jia‐Lin Li, Xi Yang, Feng Zhou, et al.
Neuropsychopharmacology (2020) Vol. 45, Iss. 6, pp. 1026-1033
Open Access | Times Cited: 13
Shifting uncertainty intolerance: methylphenidate and attention-deficit hyperactivity disorder
Alekhya Mandali, Arjun Sethi, Mara Cercignani, et al.
Translational Psychiatry (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 12
Pharmacological Strategies to Improve Mental Performance
Jeroen Van Cutsem, Nathalie Pattyn
Routledge eBooks (2024), pp. 119-134
Open Access | Times Cited: 1
The Role of Different Behavioral and Psychosocial Factors in the Context of Pharmaceutical Cognitive Enhancers’ Misuse
Tina Tomažič, Anita Kovačič Čelofiga
Healthcare (2022) Vol. 10, Iss. 6, pp. 972-972
Open Access | Times Cited: 7
Drug liking and wanting, not impulsive action or reflection is increased by 4-fluoroamphetamine
Kim P. C. Kuypers, E. B. de Sousa Fernandes Perna, Patrick C. Dolder, et al.
Psychopharmacology (2018) Vol. 235, Iss. 8, pp. 2349-2356
Open Access | Times Cited: 11
Effects of methamphetamine on neural responses to visual stimuli
Kathryne Van Hedger, Sarah K. Keedy, Kathryn E. Schertz, et al.
Psychopharmacology (2019) Vol. 236, Iss. 6, pp. 1741-1748
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top